AIFA - Allergy and Immunology Foundation of Australasia
The Allergy and Immunology Foundation of Australasia (AIFA) awarded $110,000 in grants to five outstanding allergy and immunology research projects in 2020. Congratulations to the AIFA grant recipients and thank you to our generous donors and sponsors for making these grants possible.
To read about the projects awarded in 2020 go to www.allergyimmunology.org.au/projects
The next AIFA grant round will open in March 2021, and expression of interest (EOI) forms are on the AIFA website www.allergyimmunology.org.au/grants
To be eligible for an AIFA grant the Chief Investigator must be an ASCIA member and the research needs to be carried out by the chief investigator and designated team in a non-profit institution in Australia or New Zealand.
Thank you to our expert grant selection panel, led by Dr Melanie Wong, who have volunteered their time in an extremely busy and challenging year, who select AIFA research grants each year through a robust selection process..
AIFA has awarded research grants to 18 projects since 2015, but there are many projects with great potential that still require funding, and we are now seeking support for AIFA grants in 2021.
By donating to AIFA, you can be reassured that 100% of donations to AIFA directly fund allergy/immunology research grants.
- All donations of $100 or more are perpetually acknowledged on the AIFA website www.allergyimmunology.org.au/our-supporters/donors
- Significant donors (of $10,000 or more) may request targeted research project funding in particular areas.
AIFA research grants encourage:
- Emerging researchers who may not yet receive grants from the NHMRC or other organisations.
- Innovative research that requires seed funding.
- Collaborative research projects conducted throughout Australia and New Zealand.
- Projects that will translate to better treatment and care for patients with allergy and other immune diseases.
About AIFA
AIFA was established in 2013 by ASCIA, the peak professional body for allergy and clinical immunology in Australasia. The aim of AIFA is to improve the health and care of people with allergy and other immune diseases by funding medical research in Australia and New Zealand.
Allergy and other immune system disorders (primary immunodeficiencies and autoimmune diseases) are amongst the most important chronic diseases and public health issues in Australia and New Zealand, affecting around 25% of the population. Funding of research into allergy and other immune diseases is vital for the prevention and treatment of these diseases, and to ultimately find cures.
Content updated December 2020
